English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cervical cancer is common among women worldwide, with most cases occurring in developing countries (1). Along with the development of socioeconomics associated with urbanization, as well as the aging population, the incidence and mortality of cervical cancer keep increasing in China. It was estimated to have about 132,000 new cases and 30,000 deaths each year in China (2). Early-stage cervical cancer is mainly managed by surgical resection, with a 5-year survival rate over 90%. Radiation therapy is recommended to patients with locally advanced cervical cancer, but the prognosis is relatively poor with a 5-year survival rate Original Article

Outcome evaluation of neoadjuvant chemotherapy in patients with stage IB2 or IIA cervical cancer: a retrospective comparative study